Global Point of Care Diagnostics (POCD) Market Size, Status and Forecast 2024-2031

Report ID: 955106 | Published Date: Sep 2024 | No. of Page: 127 | Base Year: 2023 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Point of Care Diagnostics (POCD) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Blood Glucose Testing
        1.2.3 Infectious Diseases Testing
        1.2.4 Cardiac Markers Testing
        1.2.5 Coagulation Testing
        1.2.6 Pregnancy and Fertility Testing
        1.2.7 Blood Gas/Electrolytes Testing
        1.2.8 Tumor Markers Testing
        1.2.9 Urinalysis Testing
        1.2.10 Cholesterol Testing
        1.2.11 Others
    1.3 Market by Application
        1.3.1 Global Point of Care Diagnostics (POCD) Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Clinics
        1.3.3 Hospitals
        1.3.4 Assisted Living Healthcare Facilities
        1.3.5 Laboratory
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Point of Care Diagnostics (POCD) Market Perspective (2016-2027)
    2.2 Point of Care Diagnostics (POCD) Growth Trends by Regions
        2.2.1 Point of Care Diagnostics (POCD) Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Point of Care Diagnostics (POCD) Historic Market Share by Regions (2016-2021)
        2.2.3 Point of Care Diagnostics (POCD) Forecasted Market Size by Regions (2022-2027)
    2.3 Point of Care Diagnostics (POCD) Industry Dynamic
        2.3.1 Point of Care Diagnostics (POCD) Market Trends
        2.3.2 Point of Care Diagnostics (POCD) Market Drivers
        2.3.3 Point of Care Diagnostics (POCD) Market Challenges
        2.3.4 Point of Care Diagnostics (POCD) Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Point of Care Diagnostics (POCD) Players by Revenue
        3.1.1 Global Top Point of Care Diagnostics (POCD) Players by Revenue (2016-2021)
        3.1.2 Global Point of Care Diagnostics (POCD) Revenue Market Share by Players (2016-2021)
    3.2 Global Point of Care Diagnostics (POCD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Point of Care Diagnostics (POCD) Revenue
    3.4 Global Point of Care Diagnostics (POCD) Market Concentration Ratio
        3.4.1 Global Point of Care Diagnostics (POCD) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Point of Care Diagnostics (POCD) Revenue in 2020
    3.5 Point of Care Diagnostics (POCD) Key Players Head office and Area Served
    3.6 Key Players Point of Care Diagnostics (POCD) Product Solution and Service
    3.7 Date of Enter into Point of Care Diagnostics (POCD) Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Point of Care Diagnostics (POCD) Breakdown Data by Type
    4.1 Global Point of Care Diagnostics (POCD) Historic Market Size by Type (2016-2021)
    4.2 Global Point of Care Diagnostics (POCD) Forecasted Market Size by Type (2022-2027)

5 Point of Care Diagnostics (POCD) Breakdown Data by Application
    5.1 Global Point of Care Diagnostics (POCD) Historic Market Size by Application (2016-2021)
    5.2 Global Point of Care Diagnostics (POCD) Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Point of Care Diagnostics (POCD) Market Size (2016-2027)
    6.2 North America Point of Care Diagnostics (POCD) Market Size by Type
        6.2.1 North America Point of Care Diagnostics (POCD) Market Size by Type (2016-2021)
        6.2.2 North America Point of Care Diagnostics (POCD) Market Size by Type (2022-2027)
        6.2.3 North America Point of Care Diagnostics (POCD) Market Size by Type (2016-2027)
    6.3 North America Point of Care Diagnostics (POCD) Market Size by Application
        6.3.1 North America Point of Care Diagnostics (POCD) Market Size by Application (2016-2021)
        6.3.2 North America Point of Care Diagnostics (POCD) Market Size by Application (2022-2027)
        6.3.3 North America Point of Care Diagnostics (POCD) Market Size by Application (2016-2027)
    6.4 North America Point of Care Diagnostics (POCD) Market Size by Country
        6.4.1 North America Point of Care Diagnostics (POCD) Market Size by Country (2016-2021)
        6.4.2 North America Point of Care Diagnostics (POCD) Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Point of Care Diagnostics (POCD) Market Size (2016-2027)
    7.2 Europe Point of Care Diagnostics (POCD) Market Size by Type
        7.2.1 Europe Point of Care Diagnostics (POCD) Market Size by Type (2016-2021)
        7.2.2 Europe Point of Care Diagnostics (POCD) Market Size by Type (2022-2027)
        7.2.3 Europe Point of Care Diagnostics (POCD) Market Size by Type (2016-2027)
    7.3 Europe Point of Care Diagnostics (POCD) Market Size by Application
        7.3.1 Europe Point of Care Diagnostics (POCD) Market Size by Application (2016-2021)
        7.3.2 Europe Point of Care Diagnostics (POCD) Market Size by Application (2022-2027)
        7.3.3 Europe Point of Care Diagnostics (POCD) Market Size by Application (2016-2027)
    7.4 Europe Point of Care Diagnostics (POCD) Market Size by Country
        7.4.1 Europe Point of Care Diagnostics (POCD) Market Size by Country (2016-2021)
        7.4.2 Europe Point of Care Diagnostics (POCD) Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Point of Care Diagnostics (POCD) Market Size (2016-2027)
    8.2 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Type
        8.2.1 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Type (2016-2027)
    8.3 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Application
        8.3.1 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Application (2016-2027)
    8.4 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region
        8.4.1 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Point of Care Diagnostics (POCD) Market Size (2016-2027)
    9.2 Latin America Point of Care Diagnostics (POCD) Market Size by Type
        9.2.1 Latin America Point of Care Diagnostics (POCD) Market Size by Type (2016-2021)
        9.2.2 Latin America Point of Care Diagnostics (POCD) Market Size by Type (2022-2027)
        9.2.3 Latin America Point of Care Diagnostics (POCD) Market Size by Type (2016-2027)
    9.3 Latin America Point of Care Diagnostics (POCD) Market Size by Application
        9.3.1 Latin America Point of Care Diagnostics (POCD) Market Size by Application (2016-2021)
        9.3.2 Latin America Point of Care Diagnostics (POCD) Market Size by Application (2022-2027)
        9.3.3 Latin America Point of Care Diagnostics (POCD) Market Size by Application (2016-2027)
    9.4 Latin America Point of Care Diagnostics (POCD) Market Size by Country
        9.4.1 Latin America Point of Care Diagnostics (POCD) Market Size by Country (2016-2021)
        9.4.2 Latin America Point of Care Diagnostics (POCD) Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Point of Care Diagnostics (POCD) Market Size (2016-2027)
    10.2 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Type
        10.2.1 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Type (2016-2027)
    10.3 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Application
        10.3.1 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Application (2016-2027)
    10.4 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country
        10.4.1 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Alere
        11.1.1 Alere Company Details
        11.1.2 Alere Business Overview
        11.1.3 Alere Point of Care Diagnostics (POCD) Introduction
        11.1.4 Alere Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
        11.1.5 Alere Recent Development
    11.2 Roche
        11.2.1 Roche Company Details
        11.2.2 Roche Business Overview
        11.2.3 Roche Point of Care Diagnostics (POCD) Introduction
        11.2.4 Roche Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
        11.2.5 Roche Recent Development
    11.3 Abbott Laboratories
        11.3.1 Abbott Laboratories Company Details
        11.3.2 Abbott Laboratories Business Overview
        11.3.3 Abbott Laboratories Point of Care Diagnostics (POCD) Introduction
        11.3.4 Abbott Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
        11.3.5 Abbott Laboratories Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Details
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Point of Care Diagnostics (POCD) Introduction
        11.4.4 Johnson & Johnson Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
        11.4.5 Johnson & Johnson Recent Development
    11.5 Siemens Healthcare
        11.5.1 Siemens Healthcare Company Details
        11.5.2 Siemens Healthcare Business Overview
        11.5.3 Siemens Healthcare Point of Care Diagnostics (POCD) Introduction
        11.5.4 Siemens Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
        11.5.5 Siemens Healthcare Recent Development
    11.6 Danaher
        11.6.1 Danaher Company Details
        11.6.2 Danaher Business Overview
        11.6.3 Danaher Point of Care Diagnostics (POCD) Introduction
        11.6.4 Danaher Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
        11.6.5 Danaher Recent Development
    11.7 QIAGEN
        11.7.1 QIAGEN Company Details
        11.7.2 QIAGEN Business Overview
        11.7.3 QIAGEN Point of Care Diagnostics (POCD) Introduction
        11.7.4 QIAGEN Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
        11.7.5 QIAGEN Recent Development
    11.8 Bayer Healthcare
        11.8.1 Bayer Healthcare Company Details
        11.8.2 Bayer Healthcare Business Overview
        11.8.3 Bayer Healthcare Point of Care Diagnostics (POCD) Introduction
        11.8.4 Bayer Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
        11.8.5 Bayer Healthcare Recent Development
    11.9 Beckman Coulter
        11.9.1 Beckman Coulter Company Details
        11.9.2 Beckman Coulter Business Overview
        11.9.3 Beckman Coulter Point of Care Diagnostics (POCD) Introduction
        11.9.4 Beckman Coulter Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
        11.9.5 Beckman Coulter Recent Development
    11.10 Nipro Diagnostics
        11.10.1 Nipro Diagnostics Company Details
        11.10.2 Nipro Diagnostics Business Overview
        11.10.3 Nipro Diagnostics Point of Care Diagnostics (POCD) Introduction
        11.10.4 Nipro Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
        11.10.5 Nipro Diagnostics Recent Development
    11.11 Bio-Rad Laboratories
        11.11.1 Bio-Rad Laboratories Company Details
        11.11.2 Bio-Rad Laboratories Business Overview
        11.11.3 Bio-Rad Laboratories Point of Care Diagnostics (POCD) Introduction
        11.11.4 Bio-Rad Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
        11.11.5 Bio-Rad Laboratories Recent Development
    11.12 Nova Biomedical
        11.12.1 Nova Biomedical Company Details
        11.12.2 Nova Biomedical Business Overview
        11.12.3 Nova Biomedical Point of Care Diagnostics (POCD) Introduction
        11.12.4 Nova Biomedical Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
        11.12.5 Nova Biomedical Recent Development
    11.13 BioMerieux
        11.13.1 BioMerieux Company Details
        11.13.2 BioMerieux Business Overview
        11.13.3 BioMerieux Point of Care Diagnostics (POCD) Introduction
        11.13.4 BioMerieux Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
        11.13.5 BioMerieux Recent Development
    11.14 Quidel
        11.14.1 Quidel Company Details
        11.14.2 Quidel Business Overview
        11.14.3 Quidel Point of Care Diagnostics (POCD) Introduction
        11.14.4 Quidel Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
        11.14.5 Quidel Recent Development
    11.15 Helena Laboratories
        11.15.1 Helena Laboratories Company Details
        11.15.2 Helena Laboratories Business Overview
        11.15.3 Helena Laboratories Point of Care Diagnostics (POCD) Introduction
        11.15.4 Helena Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
        11.15.5 Helena Laboratories Recent Development
    11.16 OraSure Technologies
        11.16.1 OraSure Technologies Company Details
        11.16.2 OraSure Technologies Business Overview
        11.16.3 OraSure Technologies Point of Care Diagnostics (POCD) Introduction
        11.16.4 OraSure Technologies Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
        11.16.5 OraSure Technologies Recent Development
    11.17 Accriva
        11.17.1 Accriva Company Details
        11.17.2 Accriva Business Overview
        11.17.3 Accriva Point of Care Diagnostics (POCD) Introduction
        11.17.4 Accriva Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
        11.17.5 Accriva Recent Development
    11.18 Abaxis
        11.18.1 Abaxis Company Details
        11.18.2 Abaxis Business Overview
        11.18.3 Abaxis Point of Care Diagnostics (POCD) Introduction
        11.18.4 Abaxis Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
        11.18.5 Abaxis Recent Development
    11.18 Chembio Diagnostics
        .1 Chembio Diagnostics Company Details
        .2 Chembio Diagnostics Business Overview
        .3 Chembio Diagnostics Point of Care Diagnostics (POCD) Introduction
        .4 Chembio Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
        .5 Chembio Diagnostics Recent Development
    11.20 Trinity Biotech
        11.20.1 Trinity Biotech Company Details
        11.20.2 Trinity Biotech Business Overview
        11.20.3 Trinity Biotech Point of Care Diagnostics (POCD) Introduction
        11.20.4 Trinity Biotech Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
        11.20.5 Trinity Biotech Recent Development
    11.21 Instrumentation Laboratory
        11.21.1 Instrumentation Laboratory Company Details
        11.21.2 Instrumentation Laboratory Business Overview
        11.21.3 Instrumentation Laboratory Point of Care Diagnostics (POCD) Introduction
        11.21.4 Instrumentation Laboratory Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
        11.21.5 Instrumentation Laboratory Recent Development
    11.22 Sekisui Diagnostics
        11.22.1 Sekisui Diagnostics Company Details
        11.22.2 Sekisui Diagnostics Business Overview
        11.22.3 Sekisui Diagnostics Point of Care Diagnostics (POCD) Introduction
        11.22.4 Sekisui Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
        11.22.5 Sekisui Diagnostics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Point of Care Diagnostics (POCD) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Blood Glucose Testing
    Table 3. Key Players of Infectious Diseases Testing
    Table 4. Key Players of Cardiac Markers Testing
    Table 5. Key Players of Coagulation Testing
    Table 6. Key Players of Pregnancy and Fertility Testing
    Table 7. Key Players of Blood Gas/Electrolytes Testing
    Table 8. Key Players of Tumor Markers Testing
    Table 9. Key Players of Urinalysis Testing
    Table 10. Key Players of Cholesterol Testing
    Table 11. Key Players of Others
    Table 12. Global Point of Care Diagnostics (POCD) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 13. Global Point of Care Diagnostics (POCD) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 14. Global Point of Care Diagnostics (POCD) Market Size by Regions (2016-2021) & (US$ Million)
    Table 15. Global Point of Care Diagnostics (POCD) Market Share by Regions (2016-2021)
    Table 16. Global Point of Care Diagnostics (POCD) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 17. Global Point of Care Diagnostics (POCD) Market Share by Regions (2022-2027)
    Table 18. Point of Care Diagnostics (POCD) Market Trends
    Table 19. Point of Care Diagnostics (POCD) Market Drivers
    Table 20. Point of Care Diagnostics (POCD) Market Challenges
    Table 21. Point of Care Diagnostics (POCD) Market Restraints
    Table 22. Global Point of Care Diagnostics (POCD) Revenue by Players (2016-2021) & (US$ Million)
    Table 23. Global Point of Care Diagnostics (POCD) Market Share by Players (2016-2021)
    Table 24. Global Top Point of Care Diagnostics (POCD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point of Care Diagnostics (POCD) as of 2020)
    Table 25. Ranking of Global Top Point of Care Diagnostics (POCD) Companies by Revenue (US$ Million) in 2020
    Table 26. Global 5 Largest Players Market Share by Point of Care Diagnostics (POCD) Revenue (CR5 and HHI) & (2016-2021)
    Table 27. Key Players Headquarters and Area Served
    Table 28. Key Players Point of Care Diagnostics (POCD) Product Solution and Service
    Table 29. Date of Enter into Point of Care Diagnostics (POCD) Market
    Table 30. Mergers & Acquisitions, Expansion Plans
    Table 31. Global Point of Care Diagnostics (POCD) Market Size by Type (2016-2021) (US$ Million)
    Table 32. Global Point of Care Diagnostics (POCD) Revenue Market Share by Type (2016-2021)
    Table 33. Global Point of Care Diagnostics (POCD) Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 34. Global Point of Care Diagnostics (POCD) Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 35. Global Point of Care Diagnostics (POCD) Market Size Share by Application (2016-2021) & (US$ Million)
    Table 36. Global Point of Care Diagnostics (POCD) Revenue Market Share by Application (2016-2021)
    Table 37. Global Point of Care Diagnostics (POCD) Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 38. Global Point of Care Diagnostics (POCD) Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 39. North America Point of Care Diagnostics (POCD) Market Size by Type (2016-2021) (US$ Million)
    Table 40. North America Point of Care Diagnostics (POCD) Market Size by Type (2022-2027) & (US$ Million)
    Table 41. North America Point of Care Diagnostics (POCD) Market Size by Application (2016-2021) (US$ Million)
    Table 42. North America Point of Care Diagnostics (POCD) Market Size by Application (2022-2027) & (US$ Million)
    Table 43. North America Point of Care Diagnostics (POCD) Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. North America Point of Care Diagnostics (POCD) Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Europe Point of Care Diagnostics (POCD) Market Size by Type (2016-2021) (US$ Million)
    Table 46. Europe Point of Care Diagnostics (POCD) Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Europe Point of Care Diagnostics (POCD) Market Size by Application (2016-2021) (US$ Million)
    Table 48. Europe Point of Care Diagnostics (POCD) Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Europe Point of Care Diagnostics (POCD) Market Size by Country (2016-2021) & (US$ Million) 
    Table 50. Europe Point of Care Diagnostics (POCD) Market Size by Country (2022-2027) & (US$ Million) 
    Table 51. Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Type (2016-2021) (US$ Million)
    Table 52. Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Application (2016-2021) (US$ Million)
    Table 54. Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2016-2021) & (US$ Million) 
    Table 56. Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2022-2027) & (US$ Million) 
    Table 57. Latin America Point of Care Diagnostics (POCD) Market Size by Type (2016-2021) (US$ Million)
    Table 58. Latin America Point of Care Diagnostics (POCD) Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Latin America Point of Care Diagnostics (POCD) Market Size by Application (2016-2021) (US$ Million)
    Table 60. Latin America Point of Care Diagnostics (POCD) Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Latin America Point of Care Diagnostics (POCD) Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Latin America Point of Care Diagnostics (POCD) Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Type (2016-2021) (US$ Million)
    Table 64. Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Type (2022-2027) & (US$ Million)
    Table 65. Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Application (2016-2021) (US$ Million)
    Table 66. Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Application (2022-2027) & (US$ Million)
    Table 67. Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2016-2021) & (US$ Million) 
    Table 68. Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2022-2027) & (US$ Million) 
    Table 69. Alere Company Details
    Table 70. Alere Business Overview
    Table 71. Alere Point of Care Diagnostics (POCD) Product
    Table 72. Alere Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 73. Alere Recent Development
    Table 74. Roche Company Details
    Table 75. Roche Business Overview
    Table 76. Roche Point of Care Diagnostics (POCD) Product
    Table 77. Roche Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 78. Roche Recent Development
    Table 79. Abbott Laboratories Company Details
    Table 80. Abbott Laboratories Business Overview
    Table 81. Abbott Laboratories Point of Care Diagnostics (POCD) Product
    Table 82. Abbott Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 83. Abbott Laboratories Recent Development
    Table 84. Johnson & Johnson Company Details
    Table 85. Johnson & Johnson Business Overview
    Table 86. Johnson & Johnson Point of Care Diagnostics (POCD) Product
    Table 87. Johnson & Johnson Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 88. Johnson & Johnson Recent Development
    Table 89. Siemens Healthcare Company Details
    Table 90. Siemens Healthcare Business Overview
    Table 91. Siemens Healthcare Point of Care Diagnostics (POCD) Product
    Table 92. Siemens Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 93. Siemens Healthcare Recent Development
    Table 94. Danaher Company Details
    Table 95. Danaher Business Overview
    Table 96. Danaher Point of Care Diagnostics (POCD) Product
    Table 97. Danaher Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 98. Danaher Recent Development
    Table 99. QIAGEN Company Details
    Table 100. QIAGEN Business Overview
    Table 101. QIAGEN Point of Care Diagnostics (POCD) Product
    Table 102. QIAGEN Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 103. QIAGEN Recent Development
    Table 104. Bayer Healthcare Company Details
    Table 105. Bayer Healthcare Business Overview
    Table 106. Bayer Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 107. Bayer Healthcare Recent Development
    Table 108. Beckman Coulter Company Details
    Table 109. Beckman Coulter Business Overview
    Table 110. Beckman Coulter Point of Care Diagnostics (POCD) Product
    Table 111. Beckman Coulter Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 112. Beckman Coulter Recent Development
    Table 113. Nipro Diagnostics Company Details
    Table 114. Nipro Diagnostics Business Overview
    Table 115. Nipro Diagnostics Point of Care Diagnostics (POCD) Product
    Table 116. Nipro Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 117. Nipro Diagnostics Recent Development
    Table 118. Bio-Rad Laboratories Company Details
    Table 119. Bio-Rad Laboratories Business Overview
    Table 120. Bio-Rad Laboratories Point of Care Diagnostics (POCD) Product
    Table 121. Bio-Rad Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 122. Bio-Rad Laboratories Recent Development
    Table 123. Nova Biomedical Company Details
    Table 124. Nova Biomedical Business Overview
    Table 125. Nova Biomedical Point of Care Diagnostics (POCD) Product
    Table 126. Nova Biomedical Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 127. Nova Biomedical Recent Development
    Table 128. BioMerieux Company Details
    Table 129. BioMerieux Business Overview
    Table 130. BioMerieux Point of Care Diagnostics (POCD) Product
    Table 131. BioMerieux Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 132. BioMerieux Recent Development
    Table 133. Quidel Company Details
    Table 134. Quidel Business Overview
    Table 135. Quidel Point of Care Diagnostics (POCD) Product
    Table 136. Quidel Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 137. Quidel Recent Development
    Table 138. Helena Laboratories Company Details
    Table 139. Helena Laboratories Business Overview
    Table 140. Helena Laboratories Point of Care Diagnostics (POCD) Product
    Table 141. Helena Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 142. Helena Laboratories Recent Development
    Table 143. OraSure Technologies Company Details
    Table 144. OraSure Technologies Business Overview
    Table 145. OraSure Technologies Point of Care Diagnostics (POCD) Product
    Table 146. OraSure Technologies Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 147. OraSure Technologies Recent Development
    Table 148. Accriva Company Details
    Table 149. Accriva Business Overview
    Table 150. Accriva Point of Care Diagnostics (POCD) Product
    Table 151. Accriva Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 152. Accriva Recent Development
    Table 153. Abaxis Company Details
    Table 154. Abaxis Business Overview
    Table 155. Abaxis Point of Care Diagnostics (POCD) Product
    Table 156. Abaxis Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 157. Abaxis Recent Development
    Table 158. Chembio Diagnostics Company Details
    Table 159. Chembio Diagnostics Business Overview
    Table 160. Chembio Diagnostics Point of Care Diagnostics (POCD) Product
    Table 161. Chembio Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 162. Chembio Diagnostics Recent Development
    Table 163. Trinity Biotech Company Details
    Table 164. Trinity Biotech Business Overview
    Table 165. Trinity Biotech Point of Care Diagnostics (POCD) Product
    Table 166. Trinity Biotech Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 167. Trinity Biotech Recent Development
    Table 168. Instrumentation Laboratory Company Details
    Table 169. Instrumentation Laboratory Business Overview
    Table 170. Instrumentation Laboratory Point of Care Diagnostics (POCD) Product
    Table 171. Instrumentation Laboratory Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 172. Instrumentation Laboratory Recent Development
    Table 173. Sekisui Diagnostics Company Details
    Table 174. Sekisui Diagnostics Business Overview
    Table 175. Sekisui Diagnostics Point of Care Diagnostics (POCD) Product
    Table 176. Sekisui Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 177. Sekisui Diagnostics Recent Development
    Table 178. Research Programs/Design for This Report
    Table 179. Key Data Information from Secondary Sources
    Table 180. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Point of Care Diagnostics (POCD) Market Share by Type: 2020 VS 2027
    Figure 2. Blood Glucose Testing Features
    Figure 3. Infectious Diseases Testing Features
    Figure 4. Cardiac Markers Testing Features
    Figure 5. Coagulation Testing Features
    Figure 6. Pregnancy and Fertility Testing Features
    Figure 7. Blood Gas/Electrolytes Testing Features
    Figure 8. Tumor Markers Testing Features
    Figure 9. Urinalysis Testing Features
    Figure 10. Cholesterol Testing Features
    Figure 11. Others Features
    Figure 12. Global Point of Care Diagnostics (POCD) Market Share by Application: 2020 VS 2027
    Figure 13. Clinics Case Studies
    Figure 14. Hospitals Case Studies
    Figure 15. Assisted Living Healthcare Facilities Case Studies
    Figure 16. Laboratory Case Studies
    Figure 17. Point of Care Diagnostics (POCD) Report Years Considered
    Figure 18. Global Point of Care Diagnostics (POCD) Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 19. Global Point of Care Diagnostics (POCD) Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 20. Global Point of Care Diagnostics (POCD) Market Share by Regions: 2020 VS 2027
    Figure 21. Global Point of Care Diagnostics (POCD) Market Share by Regions (2022-2027)
    Figure 22. Global Point of Care Diagnostics (POCD) Market Share by Players in 2020
    Figure 23. Global Top Point of Care Diagnostics (POCD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point of Care Diagnostics (POCD) as of 2020
    Figure 24. The Top 10 and 5 Players Market Share by Point of Care Diagnostics (POCD) Revenue in 2020
    Figure 25. Global Point of Care Diagnostics (POCD) Revenue Market Share by Type (2016-2021)
    Figure 26. Global Point of Care Diagnostics (POCD) Revenue Market Share by Type (2022-2027)
    Figure 27. North America Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. North America Point of Care Diagnostics (POCD) Market Share by Type (2016-2027)
    Figure 29. North America Point of Care Diagnostics (POCD) Market Share by Application (2016-2027)
    Figure 30. North America Point of Care Diagnostics (POCD) Market Share by Country (2016-2027)
    Figure 31. United States Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Canada Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Europe Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Europe Point of Care Diagnostics (POCD) Market Share by Type (2016-2027)
    Figure 35. Europe Point of Care Diagnostics (POCD) Market Share by Application (2016-2027)
    Figure 36. Europe Point of Care Diagnostics (POCD) Market Share by Country (2016-2027)
    Figure 37. Germany Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. France Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. U.K. Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Italy Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Russia Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Nordic Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Asia-Pacific Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Asia-Pacific Point of Care Diagnostics (POCD) Market Share by Type (2016-2027)
    Figure 45. Asia-Pacific Point of Care Diagnostics (POCD) Market Share by Application (2016-2027)
    Figure 46. Asia-Pacific Point of Care Diagnostics (POCD) Market Share by Region (2016-2027)
    Figure 47. China Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Japan Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. South Korea Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Southeast Asia Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. India Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Australia Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Latin America Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Latin America Point of Care Diagnostics (POCD) Market Share by Type (2016-2027)
    Figure 55. Latin America Point of Care Diagnostics (POCD) Market Share by Application (2016-2027)
    Figure 56. Latin America Point of Care Diagnostics (POCD) Market Share by Country (2016-2027)
    Figure 57. Mexico Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Brazil Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Middle East & Africa Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Middle East & Africa Point of Care Diagnostics (POCD) Market Share by Type (2016-2027)
    Figure 61. Middle East & Africa Point of Care Diagnostics (POCD) Market Share by Application (2016-2027)
    Figure 62. Middle East & Africa Point of Care Diagnostics (POCD) Market Share by Country (2016-2027)
    Figure 63. Turkey Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 64. Saudi Arabia Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 65. UAE Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 66. Alere Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 67. Roche Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 68. Abbott Laboratories Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 69. Johnson & Johnson Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 70. Siemens Healthcare Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 71. Danaher Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 72. QIAGEN Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 73. Bayer Healthcare Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 74. Beckman Coulter Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 75. Nipro Diagnostics Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 76. Bio-Rad Laboratories Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 77. Nova Biomedical Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 78. BioMerieux Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 79. Quidel Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 80. Helena Laboratories Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 81. OraSure Technologies Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 82. Accriva Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 83. Abaxis Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 84. Chembio Diagnostics Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 85. Trinity Biotech Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 86. Instrumentation Laboratory Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 87. Sekisui Diagnostics Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 88. Bottom-up and Top-down Approaches for This Report
    Figure 89. Data Triangulation
    Figure 90. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Alere
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
QIAGEN
Bayer Healthcare
Beckman Coulter
Nipro Diagnostics
Bio-Rad Laboratories
Nova Biomedical
BioMerieux
Quidel
Helena Laboratories
OraSure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech
Instrumentation Laboratory
Sekisui Diagnostics
Frequently Asked Questions
Point of Care Diagnostics (POCD) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Point of Care Diagnostics (POCD) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Point of Care Diagnostics (POCD) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Ridesharing

Ridesharing is any means of transportation in which multiple people use the same car, truck, van, ... Read More